Yun Zhong
Stock Analyst at Wedbush
(0.13)
# 4,420
Out of 4,509 analysts
411
Total ratings
40.9%
Success rate
-7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Maintained: Buy | $10 | $3.81 | +162.47% | 9 | Jul 9, 2026 | |
| ASND Ascendis Pharma | Rated: Buy | $273 → $327 | $265.22 | +23.29% | 29 | Jul 9, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Buy | $35 | $18.82 | +85.97% | 30 | Jun 30, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $34 | $20.41 | +66.59% | 21 | Jun 22, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $28 | $7.15 | +291.61% | 11 | Jun 22, 2026 | |
| RZLT Rezolute | Rated: Buy | $5 → $6 | $4.74 | +26.58% | 23 | Jun 3, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 | $4.04 | +98.02% | 24 | Jun 1, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | $17 | $4.42 | +284.62% | 2 | Jun 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $15 | $5.95 | +152.10% | 20 | May 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $94 | $59.20 | +58.78% | 16 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $11.10 | +44.14% | 15 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.24 | +146.91% | 23 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.72 | +330.11% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.50 | +77.78% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 → $118 | $129.89 | -9.15% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $4.46 | +79.37% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $2.35 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.38 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $41.10 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $34.34 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $8.63 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.321 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.23 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $98.64 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.46 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $11.35 | n/a | 2 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $26.48 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.30 | n/a | 3 | Jun 28, 2018 |
Opus Genetics
Jul 9, 2026
Maintained: Buy
Price Target: $10
Current: $3.81
Upside: +162.47%
Ascendis Pharma
Jul 9, 2026
Rated: Buy
Price Target: $273 → $327
Current: $265.22
Upside: +23.29%
Sarepta Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $35
Current: $18.82
Upside: +85.97%
MoonLake Immunotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $34
Current: $20.41
Upside: +66.59%
Sagimet Biosciences
Jun 22, 2026
Maintained: Buy
Price Target: $28
Current: $7.15
Upside: +291.61%
Rezolute
Jun 3, 2026
Rated: Buy
Price Target: $5 → $6
Current: $4.74
Upside: +26.58%
MannKind
Jun 1, 2026
Maintained: Buy
Price Target: $8
Current: $4.04
Upside: +98.02%
Kalaris Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $17
Current: $4.42
Upside: +284.62%
Wave Life Sciences
May 27, 2026
Maintained: Buy
Price Target: $15
Current: $5.95
Upside: +152.10%
BioMarin Pharmaceutical
May 21, 2026
Rated: Buy
Price Target: $94
Current: $59.20
Upside: +58.78%
May 19, 2026
Maintained: Hold
Price Target: $16
Current: $11.10
Upside: +44.14%
May 18, 2026
Maintained: Buy
Price Target: $8
Current: $3.24
Upside: +146.91%
May 8, 2026
Reiterated: Buy
Price Target: $16
Current: $3.72
Upside: +330.11%
May 8, 2026
Maintained: Buy
Price Target: $8
Current: $4.50
Upside: +77.78%
May 6, 2026
Rated: Buy
Price Target: $112 → $118
Current: $129.89
Upside: -9.15%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $4.46
Upside: +79.37%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $2.35
Upside: n/a
Mar 30, 2023
Maintained: Hold
Price Target: n/a
Current: $5.38
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $41.10
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $34.34
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $8
Current: $8.63
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $4
Current: $0.321
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.23
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $98.64
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $1.46
Upside: n/a
Feb 4, 2020
Reiterated: Buy
Price Target: $14
Current: $11.35
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $26.48
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $15.30
Upside: n/a